Brain natriuretic peptide and its precursor N-terminal prohormone brain natriuretic peptide (NT-proBNP) continue to be two main cardiac biomarkers used in risk stratifying patients with cardiopulmonary disease. This evidence concerns the gene NPPB and cor pulmonale.